Zhengye Biotechnology Holding Limited Increase (Decrease) in Accounts Receivable
Zhengye Biotechnology Holding Limited (ZYBT) reported Increase (Decrease) in Accounts Receivable of -CNY 39.71 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-04-28
CNY
| Period end | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|
| 2025-12-31 | -39.71M CNY 20-F · filed 2026-04-28 | |
| 2025-06-30 | -23.34M CNY 6-K · filed 2025-12-12 | |
| 2024-12-31 | -16.34M CNY 20-F · filed 2026-04-28 | |
| 2024-06-30 | -3.69M CNY 6-K · filed 2025-12-12 | |
| 2023-12-31 | -31.04M CNY 20-F · filed 2026-04-28 | |
| 2022-12-31 | 24.96M CNY 20-F · filed 2025-07-03 |
USD
| Period end | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|
| 2025-12-31 | -$5.68M 20-F · filed 2026-04-28 | |
| 2025-06-30 | -$3.26M 6-K · filed 2025-12-12 | |
| 2024-12-31 | -$2.24M 20-F · filed 2025-07-03 |